| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |